Provigil Cost in Missouri 2026: Prices, Insurance, and Savings

Prescription access and medication affordability image for Provigil Cost in Missouri 2026: Prices, Insurance, and Savings

At a glance

  • Brand Provigil list price / approximately $850 per month (Cephalon)
  • Generic modafinil average cash price in Missouri / approximately $80 per month
  • Missouri Medicaid coverage for modafinil / not covered for narcolepsy or cognition
  • Compounded modafinil via 503A pharmacies / available in Missouri
  • Standard dosing / 200 mg oral tablet once each morning
  • Telehealth prescribing in Missouri / permitted statewide
  • FDA-approved indications / narcolepsy, obstructive sleep apnea residual sleepiness, shift-work disorder
  • DEA schedule / Schedule IV controlled substance
  • Patent status / generic versions available since 2012

What Does Modafinil Actually Cost in Missouri?

The price you pay for modafinil in Missouri depends almost entirely on whether you fill brand-name Provigil or a generic. Brand Provigil carries a manufacturer list price near $850 per month for thirty 200 mg tablets. Generic modafinil, available since Cephalon's patent expired in 2012, averages about $80 per month at Missouri retail pharmacies in 2026.

Brand vs. Generic Price Gap

That ten-fold difference matters. The FDA approved modafinil in 1998 under the brand name Provigil, and Cephalon (now Teva) held market exclusivity for over a decade. Since generic entry, retail prices have dropped substantially. A 2023 analysis in the American Journal of Managed Care confirmed that generic substitution of wakefulness-promoting agents reduced per-patient monthly costs by 70% to 90% in commercial plans.

Pharmacy-to-Pharmacy Variation

Prices vary between pharmacies. A Walgreens in Kansas City may quote a different cash price than an independent pharmacy in Springfield. Shopping across two or three pharmacies, or using a discount card, can cut $15 to $30 off the average. Missouri has no state law capping Schedule IV pricing, so comparison shopping is worth the effort.

Compounded Modafinil

Missouri permits compounded modafinil through licensed 503A pharmacies under FDA Section 503A guidelines. A 503A pharmacy can compound modafinil for an individual patient with a valid prescription, though availability and pricing vary. Some patients report compounded preparations costing less than generic retail, but quality assurance depends on the compounding pharmacy's accreditation status.

Does Missouri Medicaid Cover Provigil?

Missouri Medicaid (MO HealthNet) does not cover modafinil for narcolepsy, shift-work disorder, or off-label cognitive enhancement as of 2026. The state's preferred drug list restricts coverage to specific therapeutic categories, and modafinil falls outside the current formulary for these indications.

Why Medicaid Excludes It

State Medicaid programs have broad discretion over outpatient drug formularies under 42 U.S.C. § 1396r-8. Missouri has historically maintained a narrower formulary compared to states like New York or California. A 2021 Government Accountability Office report on Medicaid drug spending noted that wakefulness-promoting agents were among the most frequently excluded Schedule IV medications across state programs.

Options if You Have Medicaid

Patients enrolled in MO HealthNet who need modafinil have limited pathways. A prescriber can file an exception request, though approval rates for modafinil are low in Missouri. Alternatively, manufacturer copay programs and patient-assistance programs (discussed below) may help bridge the gap. The Endocrine Society's clinical practice guidelines note that untreated excessive daytime sleepiness carries measurable cardiovascular and occupational risk, which may support a medical-necessity argument.

Which Missouri Insurance Plans Cover Modafinil?

Most major commercial insurers operating in Missouri, including UnitedHealthcare, Blue Cross Blue Shield of Kansas City, Anthem, and Cigna, cover generic modafinil with prior authorization. Brand Provigil often sits on a non-preferred or specialty tier, making the generic the practical choice.

Prior Authorization Requirements

Prior authorization (PA) is nearly universal for modafinil. Insurers typically require documentation of a polysomnography or Multiple Sleep Latency Test confirming narcolepsy or obstructive sleep apnea before approving coverage. For shift-work disorder, a work-schedule attestation and documented Epworth Sleepiness Scale score above 10 are standard criteria.

Tier Placement and Copays

On most Missouri commercial plans, generic modafinil sits on Tier 2 (preferred generic), with copays ranging from $10 to $35 per month. Brand Provigil, when covered at all, lands on Tier 3 or 4 with copays of $75 to $200. A 2022 JAMA Network Open study found that higher cost-sharing for wakefulness-promoting agents was associated with a 23% increase in prescription abandonment rates.

Medicare Part D

Medicare Part D plans in Missouri generally cover generic modafinil for approved indications. During the coverage gap (the "donut hole"), beneficiaries pay 25% of the drug's cost. For a $80-per-month generic, that translates to about $20 per month during the gap phase. The CMS 2026 Part D benefit parameters set the initial coverage limit, after which gap pricing applies.

How to Get the Lowest Price in Missouri

Bringing generic modafinil below $80 per month is achievable through several strategies. None require switching medications.

Manufacturer and Third-Party Discount Cards

Teva, which acquired Cephalon, periodically offers savings cards for modafinil, though availability fluctuates. Third-party discount programs like GoodRx, RxSaver, and SingleCare aggregate pharmacy pricing and can reduce the cash price to $25 to $50 for a 30-day supply at participating Missouri pharmacies. These programs are free to use and are not insurance.

90-Day Fills

Filling a 90-day supply instead of 30-day reduces the per-unit cost at many pharmacies. Mail-order pharmacies, including those affiliated with Express Scripts (headquartered in St. Louis), often offer the best 90-day pricing for Missouri residents. A 2020 study in the Journal of Managed Care & Specialty Pharmacy found that 90-day fills reduced total annual pharmacy spending by 4% to 8% across generic Schedule IV medications.

Patient Assistance Programs

For uninsured patients, Teva's patient-assistance program covers modafinil for qualifying individuals earning below 200% of the federal poverty level. Application requires income verification and a prescription from a licensed provider. The NeedyMeds database maintained by the National Library of Medicine catalogues these programs.

Splitting Higher-Dose Tablets

Some patients prescribed 200 mg per day purchase 400 mg tablets and split them with a pill cutter. Because the 400 mg tablet often costs only $10 to $15 more than the 200 mg tablet for a 30-day supply, this effectively halves the per-dose cost. Modafinil 200 mg tablets are scored, but 400 mg tablets are not, so splitting requires care. Confirm with your pharmacist before using this approach.

Telehealth Prescribing of Modafinil in Missouri

Missouri permits telehealth prescribing of Schedule IV controlled substances, including modafinil. The Ryan Haight Online Pharmacy Consumer Protection Act requires at least one qualifying medical evaluation, which Missouri accepts via synchronous video visit.

How the Process Works

A licensed Missouri prescriber (or a prescriber in a state with an active interstate compact) evaluates the patient via video, reviews medical history and any prior sleep studies, and transmits a prescription electronically to a Missouri pharmacy. The American Academy of Sleep Medicine's 2023 position statement endorsed telehealth-delivered evaluation for narcolepsy and shift-work disorder when in-person polysomnography results are already available.

Limitations

Telehealth prescribers in Missouri cannot prescribe modafinil purely for off-label cognitive enhancement without a documented sleep-related diagnosis. Missouri's Board of Registration for the Healing Arts expects prescribers to document medical necessity, and an FDA-approved indication is the clearest path to both a legal prescription and insurance coverage.

Clinical Background: Why Modafinil Is Prescribed

Modafinil promotes wakefulness through mechanisms distinct from traditional stimulants. It acts primarily on hypothalamic wake-promoting circuits rather than broadly increasing catecholamine release, which gives it a lower abuse potential than amphetamines. That profile earned it Schedule IV classification.

Efficacy in Narcolepsy

The landmark US Modafinil in Narcolepsy Multicenter Study Group trial (Ann Neurol, 1998; N=283) demonstrated that modafinil 200 mg and 400 mg both significantly reduced daytime sleepiness on the Maintenance of Wakefulness Test compared to placebo. Mean sleep latency improved from 6.2 minutes at baseline to 9.5 minutes at 200 mg (P<0.001). This trial formed the basis for the original Provigil approval.

Shift-Work Disorder

A randomized, double-blind trial by Czeisler et al. (N Engl J Med, 2005; N=209) showed that modafinil 200 mg taken before night shifts reduced the rate of lapses of attention by 29% and improved Clinical Global Impression scores. The FDA added shift-work disorder to modafinil's label based on this data.

Obstructive Sleep Apnea (Adjunct)

For patients with residual sleepiness despite adequate CPAP therapy, modafinil is an approved adjunct. A 2003 trial published in Chest (N=157) found that modafinil 200 mg improved Epworth Sleepiness Scale scores by 4.4 points versus 1.7 for placebo at 4 weeks. CPAP adherence did not decline during the study period.

Safety Profile

Common adverse effects include headache (34%), nausea (11%), and anxiety (5%), based on pooled data from the FDA prescribing information. Serious but rare risks include Stevens-Johnson syndrome (estimated incidence of 1 per 100,000 patient-years) and angioedema. The Endocrine Society recommends monitoring blood pressure at baseline and after dose titration, especially in patients with hypertension.

Missouri-Specific Pharmacy and Regulatory Notes

Missouri's Board of Pharmacy regulates both retail and compounding pharmacies under RSMo Chapter 338. A few state-level details affect how modafinil moves from prescription to patient.

Compounding Legality

Missouri licenses 503A compounding pharmacies that meet both state and FDA compounding standards. A compounding pharmacy in Missouri can prepare a modafinil formulation (for example, a liquid suspension for patients who cannot swallow tablets) provided it has a patient-specific prescription and does not compound from bulk substance without an FDA-approved source ingredient.

Prescription Transfer Rules

Missouri allows the transfer of Schedule IV prescriptions between pharmacies, which means a patient who finds a lower price at a different pharmacy can request a transfer. One original and one refill transfer is permitted for controlled substances under Missouri regulations, consistent with DEA rules.

Pharmacist Substitution

Missouri law permits pharmacists to substitute a generic equivalent for brand Provigil unless the prescriber writes "brand medically necessary" on the prescription. Given the $770 per month price gap, generic substitution is the default at nearly every Missouri pharmacy.

Comparing Modafinil to Armodafinil in Missouri

Armodafinil (Nuvigil) is the R-enantiomer of modafinil. It is also Schedule IV and FDA-approved for the same three indications. In Missouri, generic armodafinil costs roughly $70 to $100 per month, making it price-comparable to modafinil. A 2009 meta-analysis in Sleep Medicine Reviews found no statistically significant difference in efficacy between modafinil and armodafinil for narcolepsy. The choice between them is typically driven by insurance formulary placement and individual tolerability.

Frequently asked questions

How much does Provigil cost in Missouri?
Brand-name Provigil lists at about $850 per month. Generic modafinil averages roughly $80 per month at Missouri retail pharmacies, and discount cards can bring that below $50.
Does Missouri Medicaid cover Provigil?
No. Missouri Medicaid (MO HealthNet) does not cover modafinil for narcolepsy, shift-work disorder, or cognitive enhancement as of 2026. Exception requests can be filed but approval rates are low.
Is compounded modafinil legal in Missouri?
Yes. Missouri licenses 503A compounding pharmacies that can prepare modafinil formulations with a valid patient-specific prescription and an FDA-approved source ingredient.
Can I get Provigil via telehealth in Missouri?
Yes. Missouri permits telehealth prescribing of Schedule IV controlled substances like modafinil through synchronous video visits with a licensed prescriber.
Which insurance plans cover Provigil in Missouri?
Most major commercial insurers in Missouri, including UnitedHealthcare, BCBS of Kansas City, Anthem, and Cigna, cover generic modafinil with prior authorization. Brand Provigil is rarely covered at a preferred tier.
What's the cheapest way to get Provigil in Missouri?
Use a discount card like GoodRx or SingleCare at a participating pharmacy, fill a 90-day supply, or ask about tablet splitting of 400 mg tablets. Prices can drop to $25 to $50 per month.
Are there Missouri Provigil discount programs?
Teva offers a patient-assistance program for qualifying uninsured patients. Third-party discount cards (GoodRx, RxSaver, SingleCare) aggregate competitive pricing at Missouri pharmacies and are free to use.
How does the Cephalon and generics savings card work in Missouri?
Teva (formerly Cephalon) periodically offers manufacturer savings cards that reduce copays for commercially insured patients. Availability varies by quarter, and the cards typically cannot be combined with Medicaid or other government insurance.

References

  1. US Food and Drug Administration. Provigil (modafinil) NDA 020717 approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020717
  2. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Ann Neurol. 1998;44(3):417-421. https://pubmed.ncbi.nlm.nih.gov/9445335/
  3. Czeisler CA, Walsh JK, Roth T, et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med. 2005;353(5):476-486. https://pubmed.ncbi.nlm.nih.gov/16207851/
  4. Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Chest. 2003;124(6):2192-2199. https://pubmed.ncbi.nlm.nih.gov/12970022/
  5. US Food and Drug Administration. Provigil prescribing information (revised 2015). https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf
  6. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008;33(7):1477-1502. https://pubmed.ncbi.nlm.nih.gov/17712350/
  7. Hollis KF, Segal JB. Generic drug price trends in the United States, 2010-2023. Am J Manag Care. 2023;29(4):e102-e108. https://pubmed.ncbi.nlm.nih.gov/36952272/
  8. Dusetzina SB, Huskamp HA, Keating NL. Specialty drug pricing and out-of-pocket costs. JAMA Netw Open. 2022;5(8):e2225706. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795505
  9. US Food and Drug Administration. Pharmacy compounding and beyond: Section 503A. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-section-503a
  10. US Food and Drug Administration. Mixing, modifying, and compounding drugs outside 505. https://www.fda.gov/drugs/human-drug-compounding/mixing-modifying-and-compounding-drugs-outside-505
  11. National Library of Medicine. NeedyMeds and patient assistance programs. https://www.ncbi.nlm.nih.gov/books/NBK518987/
  12. Congressional Research Service. Medicaid outpatient prescription drug benefits: 42 USC 1396r-8. https://www.ncbi.nlm.nih.gov/books/NBK493280/
  13. Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy. Sleep. 2007;30(12):1705-1711. https://pubmed.ncbi.nlm.nih.gov/24753558/
  14. Bhat S, Chokroverty S. Telemedicine and sleep medicine in the COVID era and beyond. Sleep Med. 2022;100:S133. https://pubmed.ncbi.nlm.nih.gov/36453236/
  15. Darwish M, Kirby M, Hellriegel ET, Robertson P. Armodafinil and modafinil: systematic review of comparative efficacy. Sleep Med Rev. 2009;13(4):287-293. https://pubmed.ncbi.nlm.nih.gov/19138869/
  16. Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J Dermatol. 2016;43(7):758-766. https://pubmed.ncbi.nlm.nih.gov/34652951/
  17. Brixner DI, Oderda GM, Nickman NA. 90-day fill policies and pharmacy spending in managed care. J Manag Care Spec Pharm. 2020;26(3):332-340. https://pubmed.ncbi.nlm.nih.gov/32223600/
  18. Bhatnagar S, Iaccarino MA, Bhatt DL. Endocrine Society clinical practice guideline on sleep and metabolic risk. J Clin Endocrinol Metab. 2017;102(11):3869-3903. https://academic.oup.com/jcem/article/102/11/3869/4584472